447 filings
PRE 14A
DBVT
DBV Technologies
Preliminary proxy
8 Apr 24
4:35pm
4
Tasse Daniel
11 Mar 24
DBV Technologies / Daniel Tasse ownership change
4:15pm
8-K
DBVT
DBV Technologies
8 Mar 24
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
4:05pm
10-K
2023 FY
DBVT
DBV Technologies
Annual report
7 Mar 24
5:25pm
8-K
DBVT
DBV Technologies
7 Mar 24
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
5:17pm
SC 13G/A
4ux 9as3xa9
14 Feb 24
DBV Technologies / Venrock Healthcare Capital Partners II ownership change
8:56pm
SC 13G/A
qf108 uw867uiuo1
14 Feb 24
DBV Technologies / BRAIDWELL ownership change
4:06pm
4
2u4534yxmhyw2kikg
8 Feb 24
DBV Technologies / Adora Ndu ownership change
5:02pm
8-K
uvkqxh9
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:05am
4
im26sv3waay 1j
19 Dec 23
DBV Technologies / Pharis Mohideen ownership change
4:44pm
4
o15z k228ve
22 Nov 23
DBV Technologies / Virginie Boucinha ownership change
7:05am
4
7jwqkj
22 Nov 23
DBV Technologies / Daniel Tasse ownership change
7:04am
4
k0ca1s8w8mtdmwli
22 Nov 23
DBV Technologies / Pharis Mohideen ownership change
7:03am
S-8
neccjdzpyylk4
20 Nov 23
Registration of securities for employees
4:06pm
8-K
txozpxbketu5mkw
9 Nov 23
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
4:52pm
3
600kp
7 Nov 23
DBV Technologies / Virginie Boucinha ownership change
4:23pm
8-K/A
e71g39hjjld3a2ktu
6 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K/A
35qr0ts2nqq0p9e7ane
2 Nov 23
Departure of Directors or Certain Officers
8:00am
8-K
rrvduupvaua
31 Oct 23
Termination of a Material Definitive Agreement
4:54pm